I think if the world knows what DCvax can do, they DEMAND to use it for other tumors as well. The world will soon know that the MOA is the same (L and Direct). So applicable to almost ALL tumors.
Study Description Brief Summary: The primary purpose of the study is to determine the efficacy of an investigational therapy called DCVax(R)-L in patients with newly diagnosed GBM for whom surgery is indicated.
is Phase III trial is designed to evaluate the impact on survival time, as well as safety, in patients following treatment with DCVax(R)-L, an immunotherapy treatment for GBM.